| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/11/2023 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 122.1k | $0.00 | $0 | | 08/11/2023 |
| 08/11/2023 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 48.1k | $18.91 | $908.9k | | 08/11/2023 |
| 08/03/2023 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 26.3k | $22.57 | $593.2k | | 08/03/2023 |
| 07/03/2023 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 26.3k | $24.94 | $655.3k | | 06/30/2023 |
| 06/30/2023 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 1000 | $15.61 | $15.6k | | 06/30/2023 |
| 05/15/2023 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 70.4k | $34.55 | $2.4M | | 02/02/2022 |
| 03/15/2023 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 5.3k | $30.65 | $163.7k | | 03/15/2023 |
| 03/09/2023 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 70.4k | $31.59 | $2.2M | | 09/22/2022 |
| 01/03/2023 | GLAUKOS Corp | GKOS | Grant | | 2.9k | $0.00 | $0 | | 01/03/2023 |
| 12/31/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 605 | $12.18 | $7.4k | | 12/31/2022 |
| 10/13/2022 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 49.3k | $26.97 | $1.3M | | 10/13/2022 |
| 09/22/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 175.6k | $0.00 | $0 | | 09/22/2022 |
| 06/30/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 1000 | $11.75 | $11.7k | | 06/30/2022 |
| 06/02/2022 | GLAUKOS Corp | GKOS | Grant | | 4.4k | $0.00 | $0 | | 06/02/2022 |
| 03/15/2022 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 3.3k | $15.79 | $52.2k | | 03/15/2022 |
| 02/02/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Employee Stock Option (Right to Buy) | 143.4k | $13.08 | $1.9M | | 02/02/2022 |
| 02/02/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 175.6k | $0.00 | $0 | | 02/02/2022 |
| 01/03/2022 | GLAUKOS Corp | GKOS | Grant | | 2.5k | $0.00 | $0 | | 01/03/2022 |
| 11/29/2021 | Revance Therapeutics, Inc. | RVNC | Purchase | Common Stock | 40k | $12.90 | $515.9k | See footnote | 11/29/2021 |
| 10/13/2021 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 42.1k | $23.08 | $971.6k | | 10/13/2021 |
| 06/30/2021 | Revance Therapeutics, Inc. | RVNC | Other (acquisition) | Common Stock | 882 | $24.09 | $21.2k | | 06/30/2021 |
| 06/03/2021 | GLAUKOS Corp | GKOS | Grant | | 2.4k | $0.00 | $0 | | 06/03/2021 |
| 02/02/2021 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 40.7k | $0.00 | $0 | | 02/02/2021 |
| 02/02/2021 | Revance Therapeutics, Inc. | RVNC | Grant | Employee Stock Option (Right to Buy) | 73.7k | $28.01 | $2.1M | | 02/02/2021 |
| 01/04/2021 | GLAUKOS Corp | GKOS | Grant | | 1.2k | $0.00 | $0 | | 01/04/2021 |
| 10/13/2020 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 66.1k | $27.62 | $1.8M | | 07/23/2020 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 143.3k | $25.14 | $3.6M | | 09/30/2020 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 301k | $0.00 | $0 | | 09/30/2020 |
| 07/23/2020 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 50.9k | $0.00 | $0 | See footnote | 07/23/2020 |
| 07/23/2020 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 264.4k | $0.00 | $0 | | 07/23/2020 |
| 06/16/2020 | SI-BONE, Inc. | SIBN | Grant | Common Stock | 8.8k | $0.00 | $0 | | 06/16/2020 |
| 06/03/2020 | GLAUKOS Corp | GKOS | Grant | | 3.9k | $0.00 | $0 | | 06/03/2020 |
| 01/23/2020 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 200k | $0.00 | $0 | | 01/23/2020 |
| 10/13/2019 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 200k | $0.00 | $0 | | 10/13/2019 |
| 10/13/2019 | Revance Therapeutics, Inc. | RVNC | Grant | Employee Stock Option (Right to Buy) | 740k | $0.00 | $0 | | 10/13/2019 |
|